Anna Cogen, MD, PhD
Assistant Professor
Division of Dermatology
Director of Inpatient Dermatology Consultative Services
MD, UWMC-Roosevelt

Faculty Information


Dr. Anna Cogen is a board-certified dermatologist with an interest in infectious diseases in dermatology and complex medical dermatology. She sees patients at the UWMC Roosevelt Clinic and serves as the Director of Inpatient Dermatology Consultative Service at the UWMC Montlake Hospital.  

Dr. Cogen’s research interests include cutaneous leishmaniasis and neutrophilic dermatoses. She is also involved in the development of medical student curriculum and resident/med student inpatient dermatology education.  

Dr. Cogen is a member of the Seattle Dermatology Society, Women’s Dermatologic Society, and the American Academy of Dermatology. 


Education & Training: 
Residency in Dermatology
University of Pennsylvania
Philadelphia PA
Medical Internship
Virginia Mason Medical Center
Seattle WA
University of California, San Francisco
San Francisco, CA
University of California San Diego
Bachelor of Science
University of California, Santa Barbara
Santa Barbara, CA
Edward Bondi Resident Teaching Award
Women’s Dermatologic Society Mentorship Award
Mailing Address: 

To make an appointment with Dr. Cogen, visit the UW Medicine website.

Research & Clinical Interests
Research Interests: 
  • Treatment of Leprosy reactions
  • Cutaneous Leishmaniasis
  • Clinical trial of Mavorixafor in WHIM syndrome
Clinical Interests: 
  • Infectious Diseases in Dermatology
  • Inpatient Dermatology
  • Complex Medical Dermatology
  • Medical Education

Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, Walker SL. Biologics in Leprosy: A Systematic Review and Case Report. Am J Trop Med Hyg. 2020 May; 102 (5):1131-1136.

Cogen AL, Desai K, Elder, D, Rosenbach, M. Acute Photodistributed Exanthematous Pustulosis due to Liraglutide. JAMA Dermatol. 2019, Aug 7.

Cogen AL, Parkekh V, Gangadhar, T, Lipoff, JB. Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma. JAAD Case Rep. 2018 Jan 16; 4(2) 132-134.                             

Cogen AL, Walker SL, Roberts Ch, Hagge DA, Khadge S, Neupane KD, Lockwood DNJ. Human Beta-Defensins 2 and 3 are up-regulated in cutaneous leprosy Type 1 reactions. PLoS Negl Trop Dis. 2012 Nov;6(11): e1869.